Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21). (Q40464781)

20 September 2017

title

Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21). (English)

1 reference

20 September 2017

10

Fenaux P

1 reference

20 September 2017

11

Preudhomme C

1 reference

20 September 2017

3

Grardel-Duflos N

1 reference

20 September 2017

Leroy H

1

1 reference

20 September 2017

de Botton S

2

1 reference

20 September 2017

Darre S

4

1 reference

20 September 2017

Leleu X

5

1 reference

20 September 2017

Roumier C

6

1 reference

20 September 2017

Morschhauser F

7

1 reference

20 September 2017

Lai JL

8

1 reference

20 September 2017

Bauters F

9

1 reference

20 September 2017

publication date

1 March 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

19

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

367-372

1 reference

Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Significance of quantitative analysis of AML1/ETO transcripts in peripheral blood stem cells from t(8;21) acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

7 January 2021

A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

7 January 2021

Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

7 January 2021

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

7 January 2021

Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

7 January 2021

Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403627

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403627

1 reference

Dimensions Publication ID

20 September 2017

1005122554

0 references

1 reference